A detailed history of Middleton & CO Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Middleton & CO Inc holds 3,588 shares of EW stock, worth $252,882. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,588
Previous 3,588 -0.0%
Holding current value
$252,882
Previous $331,000 28.7%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $16,860 - $18,862
-200 Reduced 5.28%
3,588 $331,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $14,508 - $19,112
-200 Reduced 5.02%
3,788 $361,000
Q2 2023

Jul 28, 2023

SELL
$81.41 - $94.33 $141,002 - $163,379
-1,732 Reduced 30.28%
3,988 $376,000
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $169,725 - $217,288
2,485 Added 76.82%
5,720 $426,000
Q2 2022

Jul 21, 2022

SELL
$86.5 - $128.27 $8,650 - $12,827
-100 Reduced 3.0%
3,235 $308,000
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $5,098 - $6,417
-50 Reduced 1.48%
3,335 $393,000
Q3 2021

Nov 08, 2021

BUY
$102.91 - $122.75 $348,350 - $415,508
3,385 New
3,385 $383,000
Q1 2021

May 06, 2021

SELL
$78.68 - $90.67 $287,968 - $331,852
-3,660 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$71.69 - $91.23 $262,385 - $333,901
3,660 New
3,660 $334,000
Q3 2020

Oct 30, 2020

SELL
$67.19 - $87.44 $275,882 - $359,028
-4,106 Closed
0 $0
Q2 2020

Jul 28, 2020

BUY
$57.54 - $76.95 $156,623 - $209,457
2,722 Added 196.68%
4,106 $284,000
Q1 2020

Apr 22, 2020

SELL
$52.41 - $81.0 $1,519 - $2,349
-29 Reduced 2.05%
1,384 $261,000
Q4 2019

Jan 29, 2020

BUY
$71.7 - $82.09 $22,944 - $26,268
320 Added 29.28%
1,413 $330,000
Q1 2019

Apr 25, 2019

BUY
$47.89 - $64.05 $52,343 - $70,006
1,093 New
1,093 $209,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Middleton & CO Inc Portfolio

Follow Middleton & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Middleton & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Middleton & CO Inc with notifications on news.